These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33022228)

  • 21. Network degeneration and dysfunction in presymptomatic
    Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
    Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
    Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.
    Gagliardi D; Costamagna G; Taiana M; Andreoli L; Biella F; Bersani M; Bresolin N; Comi GP; Corti S
    Ageing Res Rev; 2020 Dec; 64():101172. PubMed ID: 32971256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.
    Fredi M; Cavazzana I; Biasiotto G; Filosto M; Padovani A; Monti E; Tincani A; Franceschini F; Zanella I
    Neuromolecular Med; 2019 Jun; 21(2):150-159. PubMed ID: 30859373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms.
    Silverman HE; Goldman JS; Huey ED
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):93. PubMed ID: 31773397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease progression in
    Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T
    Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The
    Crook A; McEwen A; Fifita JA; Zhang K; Kwok JB; Halliday G; Blair IP; Rowe DB
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):310-316. PubMed ID: 30907153
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies.
    Davidson YS; Robinson AC; Rollinson S; Pickering-Brown S; Xiao S; Robertson J; Mann DMA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):102-111. PubMed ID: 28766957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
    Glasmacher SA; Wong C; Pearson IE; Pal S
    JAMA Neurol; 2020 Mar; 77(3):367-376. PubMed ID: 31738367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model.
    Swaminathan A; Bouffard M; Liao M; Ryan S; Callister JB; Pickering-Brown SM; Armstrong GAB; Drapeau P
    Hum Mol Genet; 2018 May; 27(10):1754-1762. PubMed ID: 29528390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All in the Family: Repeats and ALS/FTD.
    Pattamatta A; Cleary JD; Ranum LPW
    Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
    Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
    Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
    Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR.
    Hao Z; Liu L; Tao Z; Wang R; Ren H; Sun H; Lin Z; Zhang Z; Mu C; Zhou J; Wang G
    Nat Commun; 2019 Jul; 10(1):2906. PubMed ID: 31266945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models.
    Liu Y; Dodart JC; Tran H; Berkovitch S; Braun M; Byrne M; Durbin AF; Hu XS; Iwamoto N; Jang HG; Kandasamy P; Liu F; Longo K; Ruschel J; Shelke J; Yang H; Yin Y; Donner A; Zhong Z; Vargeese C; Brown RH
    Nat Commun; 2021 Feb; 12(1):847. PubMed ID: 33558503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.